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To survive in a rapidly changing environment, animals must sense their external world
and internal physiological state and properly regulate levels of arousal. Levels of arousal
that are abnormally high may result in inefficient use of internal energy stores and
unfocused attention to salient environmental stimuli. Alternatively, levels of arousal that
are abnormally low may result in the inability to properly seek food, water, sexual
partners, and other factors necessary for life. In the brain, neurons that express hypocretin
neuropeptides may be uniquely posed to sense the external and internal state of the
animal and tune arousal state according to behavioral needs. In recent years, we have
applied temporally precise optogenetic techniques to study the role of these neurons
and their downstream connections in regulating arousal. In particular, we have found that
noradrenergic neurons in the brainstem locus coeruleus (LC) are particularly important
for mediating the effects of hypocretin neurons on arousal. Here, we discuss our recent
results and consider the implications of the anatomical connectivity of these neurons
in regulating the arousal state of an organism across various states of sleep and
wakefulness.
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Sleep and wakefulness are two mutually exclusive states that cycle
with both ultradian and circadian periods throughout the animal
kingdom. Wakefulness is a conscious state in which an animal
can perceive and interact with its environment. After prolonged
period of wakefulness, sleep pressure increases and leads to the
onset of sleep that is characterized as a period of relative inactivity
with stereotyped posture and higher sensory threshold.
In mammals, sleep is generally divided into slow-wave sleep
(SWS, or NREM sleep in humans), and rapid eye movement
(REM) sleep (also called “paradoxical sleep”). Wakefulness, SWS
and REM sleep are distinct behavioral states that can be defined
by precise electroencephalographic (EEG) and electromyographic
(EMG) features. During wake, low-amplitude, mixed-frequency
oscillations predominate. SWS is characterized by high-amplitude
slow oscillations (0.5–4Hz) whose predominance (as measured
by the EEG power density) reflects the depth of sleep. REM sleep
is a singular behavioral state, characterized by faster, mixed fre-
quencies oscillations, among which theta (5–10Hz) oscillations
dominate in rodents, accompanied by muscle atonia, as well as
fluctuation of the heart and breathing rates.
Although states of sleep and wakefulness are qualitatively and
quantitatively easy to characterize, it is surprisingly difficult to
define what is meant by “arousal.” The term arousal usually refers
to the degree of vigilance and alertness during wakefulness, man-
ifesting as increased motor activation, responsiveness to sensory
inputs, emotional reactivity, and enhanced cognitive processing.
The brain mechanisms underlying the organization of the
sleep-wake cycle and general level of arousal remain unclear and
many classical studies have identified several populations of neu-
rons whose activity correlates with distinct behavioral states. It
was originally assumed that neurons that are active before behav-
ioral transitions (i.e., neurons active preceding a sleep-to-wake
transition) promote the coming state, while neurons that are active
during a specific state (wakefulness or sleep) are important to
maintain it. This view is made more complicated by the under-
standing that neurons in a network may show state-boundary-
associated activity because of connectivity to other, more causal
neurons without being directly responsible themselves for state
transitions. Nevertheless, it has generally been inferred that
there are neural populations that play a causal role in sleep
and/or arousal states. Populations that are thought to promote
arousal include: the hypocretin (hcrt—also called “orexins”)-
expressing neurons in the lateral hypothalamus, the noradren-
ergic locus coeruleus (LC)-expressing neurons in the brainstem,
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the serotoninergic dorsal raphe nuclei (DRN) in the brainstem,
the histaminergic tuberomammilary nucleus (TMN) in the poste-
rior hypothalamus, the cholinergic pedunculopontine (PPT) and
laterodorsal tegmental (LDT) nuclei in the midbrain, as well as
cholinergic neurons in the basal forebrain (Jones, 2003). In con-
trast, inhibitory neurons from anterior hypothalamic structures
are active during SWS, while Melanin-Concentrating Hormone
(MCH) neurons from the lateral hypothalamus, as well as gluta-
matergic and GABAergic neurons from the brainstem are active
during REM sleep (Fort et al., 2009).
In recent years, we and others have begun using optoge-
netic technology with various mouse models to address questions
such as How do arousal systems regulate wakefulness and arousal?
How do they functionally interact to promote, maintain or broaden
arousal in specific contexts? In our recent studies, we have been par-
ticularly interested in neurons that express hcrt (de Lecea et al.,
1998; Sakurai et al., 1998). The hcrt are two neuro-excitatory
peptides (de Lecea et al., 1998; Sakurai et al., 1998) produced
in ∼3200 neurons in the mouse lateral hypothalamus (∼6700
and 50,000–80,000 in the rat and human brain, respectively) (de
Lecea and Sutcliffe, 2005; Modirrousta et al., 2005). These neu-
rons receive functional inputs from multiple systems distributed
in the cortex, limbic system, sub-cortical areas including the
hypothalamus itself, thalamus, and ascending projections from
the brainstem cholinergic nuclei, the reticular formation, the
midbrain raphe nuclei, and the periaqueductal gray. In turn, these
neurons project throughout the central nervous system, including
to arousal and reward centers of the brain, to neurons expressing
hcrt receptors (OX1R and OX2R). The afferent and efferent pro-
jections of hcrt neurons suggest that they play a role in multiple
hypothalamic functions including regulating the sleep/wake cycle
and goal-oriented behaviors. Interestingly, we have found that a
specific efferent projection from hcrt neurons to noradrenergic
LC neurons mediate sleep-to-wake transitions and possibly more
general aspects of arousal.
Here, we summarize recent optogenetic experiments that test
the hypothesis that hcrt and LC neurons cause arousal state tran-
sitions and maintenance (Adamantidis et al., 2007; Carter et al.,
2009, 2010, 2012). First, we briefly highlight and summarize pre-
vious reports about these systems using traditional genetic and
pharmacological techniques. Next, we integrate our own findings
using optogenetic probes to selectively stimulate or inhibit these
systems in freely-moving mice. Finally, we discuss unresolved
questions and speculate on future anatomical and functional
dissections of arousal circuits.
HYPOCRETINS, WAKEFULNESS, AND NARCOLEPSY
hcrt neurons are generally silent during quiet wakefulness, SWS,
and REM sleep but show high discharge rates during active wake
and REM sleep-to-wake transitions (Lee et al., 2005; Mileykovskiy
et al., 2005; Takahashi et al., 2008; Hassani et al., 2009). In addi-
tion, they show high discharge rates during arousal elicited by
environmental stimuli (e.g., an auditory stimulus) (Takahashi
et al., 2008) and goal-oriented behavior (Mileykovskiy et al., 2005;
Takahashi et al., 2008). These studies suggest that hcrt neurons
participate to sleep-to-wake transitions, as well as in the increased
alertness observed during various goal-oriented behaviors.
Blockade or suppression of hcrt signaling demonstrates the
necessity of hcrt for the integrity of behavioral states in mice,
rats, dogs, humans, and possibly zebrafishes (Sakurai, 2007;
Yokogawa et al., 2007). Indeed, the most compelling loss-of-
function evidence comes from the link between hcrt deficiency
and the symptoms of narcolepsy (Peyron et al., 2000; Saper
et al., 2010). Narcoleptic patients with cataplexy have a com-
plete absence of hcrt gene transcripts in the hypothalamus as well
as non- or barely-detectable levels of hcrt in the cerebrospinal
fluid (Thannickal et al., 2000; Sakurai, 2007; Yokogawa et al.,
2007). Doberman narcoleptic dogs bear a mutation in OX2R,
and all genetically engineered rodents with either a deletion of
hcrt, OX2R, or hcrt cells present behavioral arrests that resem-
ble cataplexy, the hallmark of narcolepsy (Jones, 2003; Sakurai,
2007; Sehgal and Mignot, 2011). Importantly, genetic rescue of
hcrt gene expression alleviated narcolepsy symptoms in mice (Liu
et al., 2011; Blanco-Centurion et al., 2013).
Intracerebroventricular (i.c.v.) infusion of hcrt peptides or
hcrt agonists causes an increase in the time spent awake and
a decrease in SWS and REM sleep [review in Sakurai (2007)].
Stereotactic injection of the peptide in the LC, LDT, basal fore-
brain, or the lateral hypothalamus increased wakefulness and
locomotor activity often associated with a marked reduction in
SWS and REM sleep (Hagan et al., 1999). More recently, genetic
dis-inhibition of hcrt neurons using a selective GABA-B receptor
gene deletion only in hcrt neurons induced severe fragmenta-
tion of sleep/wake states during both the light and dark periods
without showing an abnormality in total sleep/wake durations
or signs of cataplexy (Matsuki et al., 2009). Collectively, these
data suggest that the hcrt peptides are important to define
boundaries between sleep and wake states, as shown by the
fragmentation of sleep and wake state in animal models of nar-
colepsy.
Although it is widely documented that the biological function
of hcrt peptides is necessary to maintain appropriate arousal and
sleep, it remains unclear which of the two hcrt receptors, OX1R,
or OX2R, is biologically responsible for hcrt’s effects on arousal,
as well as sleep stability and muscle tone control. OX1R mRNA is
expressed in many brain areas, in particular the LC, raphe nuclei,
LDT while OX2R mRNA shows a complementary pattern of
expression in cerebral cortex, raphe nuclei, as well as dorsomedial
and posterior (in the tuberomammillary nucleus) hypothalamus
(Trivedi et al., 1998; Marcus et al., 2001; Mieda et al., 2011).
Thus, it has been proposed that the control of wakefulness and
NREM sleep-to-wake depends critically on OX2R (Mochizuki
et al., 2011) while the dysregulation of REM sleep (unique to
narcolepsy-cataplexy) results from loss of signaling through both
OX1R andOX2R (Mieda et al., 2011). However, their implications
in the regulation of narcolepsy, in particular cataplexy and sleep
attack, remain unclear. Dogs with heritable narcolepsy bear a null
mutation in the OX2R gene (Lin et al., 1999) and the correspond-
ing mouse model, theOX2R KOmice, show less severe symptoms
than the dogs (Willie et al., 2003). Although OX1R participates to
the regulation of arousal (Mieda et al., 2011), its contribution to
the symptoms of narcolepsy remains to be further characterized.
Importantly, activity in other arousal systems is strongly per-
turbed during cataplexy. LC neurons cease discharge (Gulyani
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et al., 1999) and serotoninergic neurons significantly decrease
their activity (Wu, 2004), while cells located in the amygdala
(Gulyani et al., 2002) and the TMN showed an increased level
of firing (John et al., 2004). This association suggests that both
OX1R (LC, raphe), and OX2R (TMN, raphe) are involved in
the maintenance of appropriate muscle tone. Recent studies also
highlighted the role of altered cholinergic systems in triggering
cataplexy in narcoleptic mice (Kalogiannis et al., 2011, 2010).
Therefore, an important, unresolved goal is to identify the func-
tional wiring of hcrt neurons, as well as the dynamics of synaptic
release from hcrt terminals to precisely delineate the downstream
projections (de Lecea et al., 2012) that control arousal, sleep
states, muscle tone, and goal-oriented behaviors.
THE LOCUS COERULEUS, NOREPINEPHRINE, AND AROUSAL
The LC is adjacent to the 4th ventricle in the brainstem and
contains neurons that synthetize the monoamine norepinephrine
(NE). Although four other cell populations also produce NE
(the A1, A2, A5, and A7 cell groups), the LC produces ∼50%
of the brain’s total NE and is the only source to the cor-
tex. There are many functional NE receptors located through-
out the brain, with α1 and β receptors usually causing exci-
tatory postsynaptic potentials and α2 receptors usually caus-
ing inhibitory postsynaptic potentials. α2 receptors are densely
found on LC neurons (Berridge and Waterhouse, 2003) them-
selves and serve as inhibitory autoreceptors to suppress intrinsic
activity.
Recordings in awake behaving animals show that LC neurons
fire tonically at 1–3Hz during awake states, fire less during SWS
sleep, and are virtually silent during REM sleep (Aston-Jones
and Bloom, 1981; Jones, 2003; Saper et al., 2010). The LC also
fires phasically in short bursts of 8–10Hz during the presenta-
tion of salient stimuli that may increase wake duration. Like hcrt
neurons, alterations in discharge rate precede changes in sleep-
to-wake transitions (Aston-Jones and Bloom, 1981), suggesting
that these cells are important for transitions to wakefulness or
attention.
Interestingly, physical lesions of the LC do not elicit consis-
tent changes in cortical EEG or behavioral indices of arousal
(Lidbrink, 1974; Blanco-Centurion et al., 2007). Genetic abla-
tion of dopamine beta-hydroxylase, an enzyme required for
NE synthesis, also does not disrupt sleep-wake states (Hunsley
et al., 2006). This suggests the presence of redundant neural
circuitry, external to the LC structure, supporting cortical activ-
ity and compensatory developmental mechanisms, respectively.
However, central injections of pharmacological antagonists of α1
and β noradrenergic receptors (Berridge and España, 2000) or
agonists of inhibitory α2 autoreceptors (De Sarro et al., 1987)
have substantial sedative effects. Central administration of NE
directly into the ventricles or forebrain promotes wakefulness
(Segal and Mandell, 1970; Flicker and Geyer, 1982). Stimulation
of neurons in the LC using local microinjections of a cholinergic
agonist (bethanechol) produces rapid activation of the forebrain
EEG in halothane-anesthetized rats (Berridge and Foote, 1991).
Recently, the LC-NE system was shown to be critical for main-
taining the increased membrane potential of cortical neurons
in awake compared to sleep states (Constantinople and Bruno,
2011). Taken together, these studies imply that the LC-NE system
desynchronizes cortical activity and increases cortical membrane
potential to increase arousal.
OPTOGENETIC DISSECTION OF hcrt AND LC-NE CONTROL
OF AROUSAL
The activity of hcrt and LC-NE neurons correlates with sleep-
to-wake transitions, however, it has been difficult to selectively
stimulate or inhibit specific hcrt and LC-NE populations with
a temporal resolution relevant to sleep or wakefulness episodes,
and to achieve spatial selectivity to probe those cells without
affecting surrounding cells or fibers-of-passage. In an effort to
better understand the temporal dynamics of neural circuits of
wakefulness, we recently applied optogenetics to reversibly and
selectively manipulate the activity of hcrt and LC neurons in
freely-moving animals (Adamantidis et al., 2007; Carter et al.,
2009, 2010, 2012). Optogenetics uses actuator opsin molecules
(e.g., channelrhodopsin-2 (ChR2) or halorhodopsin—NpHR) to
selectively activate or silence genetically-targeted cells, respec-
tively, with flashes of light at specific wavelength (Boyden et al.,
2005). Further information about optogenetic technology can
be found in many other excellent reviews (Zhang et al., 2006;
Miesenbock, 2009; Scanziani and Häusser, 2009; Yizhar et al.,
2011; Deisseroth, 2012).
To deliver these actuators to hcrt or LC neurons, we used
lentiviral and cre-dependent adeno-associated viral (AAV) gene
delivery tools, respectively, under the control of cell-type spe-
cific promoters (Adamantidis et al., 2007). To deliver light to the
hcrt or LC field, we designed optical-neural interfaces in which
optical fibers were chronically implanted on the mouse skull, as
described elsewhere (Adamantidis et al., 2005, 2007; Aravanis
et al., 2007; Zhang et al., 2010). Using this strategy, we were
able to control hcrt neural activity both in vitro and in vivo
with millisecond-precise optical stimulation (Adamantidis et al.,
2007). The high temporal and spatial precision of stimulation
allowed us to mimic the physiological range of hypocretin neu-
ron discharge rates (1–30Hz) (Hassani et al., 2009). Indeed, we
used light pulse trains for our optogenetic stimulation that were
based on parameters on the actual frequency analysis of hcrt neu-
rons in vivo (this is also true for optogenetic control of LC-NE
neurons described below). We found that direct unilateral optical
stimulation of hcrt neurons increased the probability of transi-
tions to wakefulness from either SWS or REM sleep (Figure 1A).
Interestingly, high frequency optical stimulation (5–30Hz light
pulse trains) reduced the latency to wakefulness whereas 1Hz
trains did not, suggesting a frequency-dependent synaptic release
of neurotransmitter (glutamate) and neuromodulators, includ-
ing hcrt or dynorphin from the terminals. We further showed
that the effects of stimulating hcrt neurons could be blocked
by injection of a OX1R antagonist or by genetic deletion of the
hcrt gene, suggesting that hcrt peptides mediate, at least in part,
optogenetically-induced sleep-to-wake transitions. These results
show that hcrt release from hcrt-expressing neurons is necessary
for the wake-promoting properties of these neurons. Importantly,
these results demonstrate a causal link between hcrt neuron acti-
vation and sleep-to-wake transitions, consistent with previous
correlative studies. This was further supported by the fact that
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FIGURE 1 | Optogenetic dissection of arousal circuits of the brain.
(A) Stimulation of hcrt neurons with ChR2 causes a decrease in
sleep-to-wake latency at 10Hz but not 1Hz (data from Adamantidis
et al., 2007). (B) Stimulation of LC neurons with ChR2 causes
immediate sleep-to-wake transitions at 10Hz (data from Carter
et al., 2010). (C) Stimulation of hcrt neurons at 10Hz fails to
decrease sleep-to-wake latencies when the LC is concomitantly
inhibited with NpHR (data from Carter et al., 2012). (D) Stimulation
of the LC with a mutated version of ChR2 called a
step-function-opsin (sfo) that increases membrane excitability
enhances hcrt-mediated sleep-to-wake transitions (data from Carter
et al., 2012). ∗∗P < 0.01; ∗∗∗P < 0.0001.
optical silencing of hcrt neurons promote SWS (Tsunematsu
et al., 2011).
These results were recently confirmed by Sasaki and col-
laborators (Sasaki et al., 2011), who used a pharmacogenetic
approach called Designer Receptors Exclusively Activated by
Designer Drugs (DREADDs) to activate and suppress hcrt neu-
ral activity. DREADD technology allows bimodal modulation
of neural activity with temporal resolution of several hours
(Dong et al., 2010). They found that activation of hcrt neural
activity increased wakefulness while suppression of hcrt activity
promoted SWS.
In a second study (Carter et al., 2009), we demonstrated that
hcrt control of sleep-wake transitions is under the dependence
of sleep homeostasis processes since hcrt-mediated sleep-to-wake
transitions are blocked by increased sleep pressure (caused by
sleep deprivation). However, the effect of optogenetic stimula-
tions of hcrt persisted in histamine decarboxylase knockout mice
(mice that are unable to synthesize histamine) suggesting that
another target that the histaminergic system is responsible for the
effect of the hcrt. Finally, we showed that downstream arousal
centers such as the LC neurons both increased their activity (as
measured by c-Fos expression) in response to hcrt optogenetic
stimulation. Because previous work showed an excitatory effect
of hcrt on LC NE neurons (Bourgin et al., 2000), we investigated
the hcrt-LC connection and focused our experimental investiga-
tions on the noradrenergic LC as a new target for optogenetic
manipulation.
In a third study (Carter et al., 2010), we genetically targeted
LC-NE neurons by stereotaxic injection of a Cre recombinase-
dependent adeno-associated virus (rAAV) into knock-in mice
selectively expressing Cre in tyrosine hydroxylase (TH) neurons
(Atasoy et al., 2008; Tsai et al., 2009). We found that both NpHR
and ChR2 were functional and could inhibit and activate, respec-
tively, LC-NE neurons both in vitro and in vivo (Figure 1B).
We found that optogenetic low frequency (1–10Hz) stimulation
of LC-NE neurons caused immediate (less than 5 s) sleep-to-
wake transitions from both SWS and REM sleep. Stimulation
of LC neurons during wakefulness increased locomotor activity
and the total time spent awake, confirming the strong arousal
effect. In contrast, NpHR-mediated silencing of LC-NE neurons
decreased the duration of wake episodes but did not block sleep-
to-wake transitions when animals were asleep. Taken together,
this study showed that activation of LC-NE neurons is necessary
for maintaining normal durations of wakefulness (NpHR exper-
iment), and sufficient to induce immediate sleep-to-wake tran-
sitions, sustained wakefulness, and increased locomotor arousal.
Thus, we proposed that the LC-NE neurons act as a fast tun-
ing system to promote sleep-to-wake transitions and general
arousal. Interestingly, we found that sustained optical activa-
tion of LC-NE neurons induces locomotor arrest (Carter et al.,
2010). Such behavioral arrests share common symptoms with cat-
aplexy, catatonia or behavioral freezing both in animal models
and human patients (Scammell et al., 2009). Possible mechanisms
may involve NE depletion from LC-NE synapse terminals or
LC-NE overexcitation of brainstem motor nuclei that would lead
to paralysis. Further study is required to unravel the underlying
mechanisms.
In our most recent study (Carter et al., 2012), we tested the
hypothesis that LC activity gates hcrt neuron’s effects on sleep-
to-wake transitions. Because hcrt and LC neural populations are
located in distinct brain regions, it is physically possible to access
both structures simultaneously in the same animal. We therefore
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took a dual optogenetic approach to stimulate hcrt neurons while
concomitantly inhibiting or stimulating noradrenergic LC neu-
rons during SWS sleep. We found that silencing LC neurons
during hcrt stimulation blocked hcrt-mediated sleep-to-wake
transitions (Figure 1C). In contrast, we found that increasing the
excitability of LC neurons through step-function opsin (SFO)
activation—which increase of target cells (Berndt et al., 2009)—
during hcrt stimulation (using a LC stimulation protocol that by
itself does not increase sleep-to-wake transitions) enhanced hcrt-
mediated sleep-to-wake transitions (Figure 1D). Taken together,
our results show that the LC serves as a necessary and sufficient
downstream effector for hcrt-mediated SWS-to-wake transitions
during the inactive period.
hcrt AND LC-NE SYSTEM DYNAMICS
Across our experimental studies, we observed that optoge-
netic manipulation of hcrt and LC-NE neurons affect sleep-to
wake transitions with dramatically different temporal dynamics
(Adamantidis et al., 2007; Carter et al., 2009, 2010, 2012). Acute
optical activation of hcrt neurons causes sleep-to-wake transi-
tions over a time period of 10–30 s, while stimulation of LC
neurons causes sleep-to-wake transitions in less than 5 s. One
explanation is that hcrt neurons may act as an upstream inte-
grator of arousal during hypothalamic-related functions while
the LC-NE system acts as a primary effector for arousal, stress,
and attention. However, the neuronal effector systems are likely
redundant and activated by distinct sets of inputs. Therefore,
we cannot rule out that blocking other arousal systems, such
as the central histaminergic and cholinergic systems, would also
severely affect hcrt-induced behavioral state transitions in other
experimental conditions.
Besides these short-term effects, it is also interesting that
sustained (i.e., semi-chronic) photostimulation experiments
of ∼1–4h of hcrt neurons increased sleep-to-wake transi-
tions without changing the total duration of wakefulness,
whereas long-term photostimulation of LC-NE neurons sig-
nificantly increased wakefulness duration. These results sug-
gest that the hcrt system may regulate sleep-wake boundaries
while LC-NE neurons may rather control wake duration by
increasing cortical membrane potential and desynchronizing the
cortical EEG.
The hypothalamic localization of hcrt neurons implies that
these cells have a prominent arousal role during homeostatic pro-
cesses, including sexual behavior, food foraging, stress response,
and motivation. Besides their control of wakefulness, arousal
systems also participate in reward-seeking behavior, sexual activ-
ity, flight-or-fight responses, etc. This redundancy may have
consolidated arousal function across evolution and diversified
brain mechanisms supporting wakefulness and arousal-related
behaviors necessary for survival. For example, activation of the
LC-NE system increases arousal and cause anxiety-like behaviors
(Itoi and Sugimoto, 2010). In contrast, the neuropeptide S (NPS)
system, a peptide produced by a restricted neuronal population
ventral to the LC, also increases arousal but decreases anxiety
(Pape et al., 2010). Thus, to support such diverse behavioral
functions, arousal circuits must have reached a high level of spec-
ification, possibly through a selective compartmentalization of
their afferent and efferent connections, transmitters/modulators
release capabilities and coherent activity with others arousal
circuits.
PERSPECTIVES
In the past five years, the combination of optogenetics,
genetically-engineered mouse models, and EEG/EMG analysis of
sleep has provided a unique and powerful set of tools to fur-
ther understand the contributions of the hcrt and LC systems
to arousal, as well as other populations of neurons that regulate
degrees of sleep and wakefulness. Targeting optogenetic probes
to other populations of neurons in the brain will determine
their individual and combined roles in sleep/wake boundaries.
Furthermore, these tools will allow us to determine the brain
mechanism underlying wake states based on anatomical projec-
tions, synaptic neurotransmission, and dynamics of transmitter
release. The ability to target and selectively manipulate these
circuits with high temporal precision (<1 s) further allows the
possibility to investigate their role in a wide spectrum of behav-
iors such as food intake, addiction, stress, attention, and sexual
arousal. Ultimately, these studies may unravel the pathophys-
iological mechanisms of psychiatric disorders such as chronic
anxiety, addiction, attention deficit, and depression.
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